A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT03466411 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03466411
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-13
- Primary completion
- 2023-10-20
- Enrollment
- 1409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.